Form 4: Standard Biotools CEO Reports Stock Transaction
Insider Transaction (Form 4)
Michael Egholm, President & CEO and a Director of Standard Biotools Inc., reported a transaction in 97,627 shares of common stock on August 20, 2026.
Summary
- Tax/exercise-price withholding: disposed of 97,627 Common Stock at $0.67 ($65,605) on August 20, 2026; holds 6,137,704 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael Egholm — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Tax/exercise-price withholding | Common Stock | 97,627 | $1 | $65.6K | 6,137,704 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Tax/exercise-price withholding (97,627 shares) |
Keywords
insider transaction, Form 4, LAB, STANDARD BIOTOOLS INC., neutral, Michael Egholm
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.